WO2004069177A3 - Methods for modulating an inflammatory response - Google Patents
Methods for modulating an inflammatory response Download PDFInfo
- Publication number
- WO2004069177A3 WO2004069177A3 PCT/US2004/002767 US2004002767W WO2004069177A3 WO 2004069177 A3 WO2004069177 A3 WO 2004069177A3 US 2004002767 W US2004002767 W US 2004002767W WO 2004069177 A3 WO2004069177 A3 WO 2004069177A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modulating
- methods
- inflammatory response
- wsx
- animal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04707360A EP1587483A4 (en) | 2003-01-31 | 2004-02-02 | Methods for modulating an inflammatory response |
JP2006503215A JP4909069B2 (en) | 2003-01-31 | 2004-02-02 | Methods for modulating inflammatory responses |
AU2004209967A AU2004209967B9 (en) | 2003-01-31 | 2004-02-02 | Methods for modulating an inflammatory response |
MXPA05008131A MXPA05008131A (en) | 2003-01-31 | 2004-02-02 | Methods for modulating an inflammatory response. |
CA2514641A CA2514641C (en) | 2003-01-31 | 2004-02-02 | Methods for modulating an inflammatory response |
AU2009203080A AU2009203080B9 (en) | 2003-01-31 | 2009-07-29 | Methods for Modulating an Inflammatory Response |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44449403P | 2003-01-31 | 2003-01-31 | |
US60/444,494 | 2003-01-31 | ||
US51907403P | 2003-11-10 | 2003-11-10 | |
US60/519,074 | 2003-11-10 | ||
PCT/US2004/002646 WO2004069173A2 (en) | 2003-01-31 | 2004-01-30 | Methods for modulating an inflammatory response |
USPCT/US04/02646 | 2004-01-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004069177A2 WO2004069177A2 (en) | 2004-08-19 |
WO2004069177A3 true WO2004069177A3 (en) | 2006-01-12 |
Family
ID=32851399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/002767 WO2004069177A2 (en) | 2003-01-31 | 2004-02-02 | Methods for modulating an inflammatory response |
Country Status (2)
Country | Link |
---|---|
MX (1) | MXPA05008131A (en) |
WO (1) | WO2004069177A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4839434B2 (en) * | 2005-03-14 | 2011-12-21 | 千葉県 | Pharmaceutical formulation containing p28 molecule or gene thereof |
US20100008917A1 (en) * | 2006-08-25 | 2010-01-14 | Nancy Hosken | Treatment of aplastic anemia |
EP2054075A1 (en) * | 2006-08-25 | 2009-05-06 | Zymogenetics, Inc. | Treatment of graft-versus-host disease |
RU2644346C2 (en) | 2011-06-01 | 2018-02-08 | Интрексон Актобиотикс Н.В. | System of polycistronic expression for bacteria |
CA3011331A1 (en) | 2016-01-14 | 2017-07-20 | Intrexon Actobiotics N.V. | Compositions and methods for the treatment of type 1 diabetes |
-
2004
- 2004-02-02 WO PCT/US2004/002767 patent/WO2004069177A2/en active Application Filing
- 2004-02-02 MX MXPA05008131A patent/MXPA05008131A/en active IP Right Grant
Non-Patent Citations (2)
Title |
---|
See also references of EP1587483A4 * |
SPRECHER C. ET AL: "Cloning and Characterization of a Novel Clas 1 Cytokine Receptor.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS., vol. 246, 1998, pages 82 - 90, XP002174914 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004069177A2 (en) | 2004-08-19 |
MXPA05008131A (en) | 2005-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006031878A3 (en) | Imidazoquinoline compounds | |
WO2006069241A3 (en) | Methods for promoting oral health in animals | |
WO2006138418A3 (en) | Improvement of cognitive performance with sirtuin activators | |
WO2004069173A3 (en) | Methods for modulating an inflammatory response | |
WO2006002976A3 (en) | Canine osteoarthritis diet formulation | |
WO2005004818A3 (en) | Heterocyclic compounds and their use as anticancer agents | |
WO2007109812A3 (en) | Immunopotentiating compounds | |
EP2592073A3 (en) | Human protein tyrosine phosphatase inhibitors and their use | |
TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
WO2007120528A3 (en) | Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases | |
WO2007070052A3 (en) | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease | |
WO2005003172A3 (en) | Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy | |
WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
WO2007084221A3 (en) | Methods and apparatus for identifying subject matter in view data | |
EP2592072A3 (en) | Human protein tyrosine phosphatase inhibitors and their use | |
WO2006105359A3 (en) | Methods for stimulating hair growth by administering bmps | |
WO2007092065A3 (en) | Compounds and compositions as lxr modulators | |
WO2007064885A3 (en) | Oral care compositions, methods, devices and systems | |
WO2005077122A3 (en) | Compounds and compositions as lxr modulators | |
WO2008087367A3 (en) | Substituted (phenylthiazolyl)-phenyl-propan-1-one and (phenyloxazodyl)-phenyl-propan-1-one derivatives, preparations and uses of same | |
WO2006118884A3 (en) | Drug delivery devices and related components, systems and methods | |
MXPA05000765A (en) | 5-aryltetrazole compounds, compositions thereof, and uses therefor. | |
WO2009038095A1 (en) | Composition comprising sesamin component and vitamin b1 component | |
EP1608395A4 (en) | Anticancer agent comprising lk8 protein as an active ingredient | |
WO2005077124A3 (en) | Compounds and compositions as lxr modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2005/008131 Country of ref document: MX Ref document number: 2514641 Country of ref document: CA Ref document number: 2004707360 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006503215 Country of ref document: JP Ref document number: 2004209967 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2004209967 Country of ref document: AU Date of ref document: 20040202 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004209967 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004707360 Country of ref document: EP |